Bisindole natural products: A vital source for the development of new anticancer drugs

Mengwei Xu1, Rui Peng1, Qing Min1

  • 1School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, PR China; Hubei Engineering Research Center of Traditional Chinese Medicine of South Hubei Province, Xianning Medical College, Hubei University of Science and Technology, Xianning, PR China.

Insights

Bisindole alkaloids from natural products show potent anticancer activity. This review details 242 bisindoles, highlighting their potential for future cancer therapeutics and clinical research.

Area of Science:

  • Natural Product Chemistry
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Global cancer incidence and mortality rates are rising, necessitating effective treatments.
  • Natural products, particularly bisindoles, have demonstrated significant anticancer potential.
  • Existing bisindole-derived drugs like vincristine and midostaurin validate their therapeutic value.

Purpose of the Study:

  • To review the therapeutic potential of bisindole alkaloids from natural sources for cancer treatment.
  • To summarize research progress on 242 bisindole alkaloids with anticancer properties.

Main Methods:

  • Literature review of bisindole alkaloids and their anticancer activities.
  • Analysis of structural diversity and mechanisms of action of bisindole compounds.
  • Compilation of data on 242 identified bisindole alkaloids.

Main Results:

  • Bisindoles exhibit enhanced anticancer activity compared to their monomeric indole units.
  • A wide array of bisindole structures with diverse mechanisms of action have been identified.
  • Established bisindole drugs confirm their clinical relevance in oncology.

Conclusions:

  • Bisindole alkaloids represent a promising class of compounds for cancer therapy.
  • Further research into these natural products could lead to novel clinical applications.
  • The reviewed bisindoles hold potential for future drug development in oncology.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K